The spillover effect continues to be released, and Abbott's global innovation achievements are constantly landing in China
胡胡胡美丽_ss
发表于 2024-10-26 20:00:34
165
0
0
Abbott recently held the 7th Abbott Technology Day and CIIE Preview. From the world's first to its debut in China, from the exhibition booth to clinical and patient settings, the spillover effects of the CIIE continue to be released, and Abbott's global innovation achievements continue to land in China. On this year's Technology Day, Abbott unveiled in advance the heavyweight exhibits and highlight activities of this year's CIIE.
As the pioneer of implantable pacemakers, Abbott insists on innovation in improving the diagnostic efficiency and treatment quality of arrhythmia. Since 2022, the Abbott AVEIR VR single chamber implantable leadless cardiac pacemaker, which is used to treat bradycardia, has embarked on an exciting journey in China through the "gateway to innovation". This year, it was successfully approved for market in China and completed the first batch of implantation surgeries.
At this year's CIIE, the AVEIR DR dual chamber implantable leadless cardiac pacemaker will also be unveiled. As the world's first truly synchronized dual chamber wireless pacemaker, it can achieve interconnection communication between the right atrium and right ventricle devices and true dual chamber wireless pacing through Abbott's unique i2i communication technology.
In addition, Abbott's Instant Series blood glucose monitoring system covers digital solutions from individuals to hospitals. At the Science and Technology Day event, Abbott announced in advance the upcoming launch of the Instant Sensing 2 Continuous Glucose Monitoring System at the CIIE. It does not require fingertip blood collection and can view glucose levels in real time through sensors and mobile applications. It also adds Bluetooth transmission and optional high and low blood sugar alarm functions, ensuring stable and healthy blood sugar levels.
It is reported that the annual CIIE is an important opportunity for Abbott to comprehensively showcase cutting-edge technology and innovative achievements in fields such as diagnosis, medical devices, nutrition, and pharmaceuticals. In addition to heavyweight exhibits this year, Abbott will also hold a variety of booth activities during the CIIE, such as themed salons and health science popularization.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Yum China announces share buyback plan involving approximately $360 million
- Yum China announces plans to repurchase approximately $360 million worth of shares
- General Motors China responds to rumors of 'General Motors plans to restructure its business in China'
- Starbucks' '' China Anxiety '
- The three major indexes of the US stock market collectively closed down, while the Nasdaq China Golden Dragon Index rose more than 8% and tripled. Go long, FTSE China ETF rose nearly 24%
- Global market: Chinese assets explode, China Golden Dragon Index rises 8.54%, 3-fold long, FTSE China ETF rises nearly 24%
- China's US Treasury holdings hit the lowest level in over 15 years in October! Is the wave of US debt reduction spreading globally?
- What is the impact of the Biden administration's 301 investigation on China's mature process chip industry?
- Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs
- Chinese assets suddenly exploded! Multiple Chinese concept stocks rose by over 10%